The Worldwide Diabetes Therapeutics Industry is Projected to Reach $3.3 Billion by 2030
12 oct. 2022 07h33 HE
|
Research and Markets
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Diabetes Therapeutics Market By Product: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
Smart Insulin Pens Global Market to Reach $214.05 Million by 2027 at a CAGR of 12.81%
11 oct. 2022 08h48 HE
|
Research and Markets
Dublin, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The "Smart Insulin Pens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Insights on the Rapid Acting Insulin Global Market to 2027 - by Product, Indication, Distribution Channel and Region
22 août 2022 08h43 HE
|
Research and Markets
Dublin, Aug. 22, 2022 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Human Insulin Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
15 juil. 2022 06h03 HE
|
Research and Markets
Dublin, July 15, 2022 (GLOBE NEWSWIRE) -- The "Human Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
APAC Insulin Syringes Industry to 2027 - Players Include Novo Nordisk, Biocon, Eli Lilly and Company and Abbott Laboratories
24 mai 2022 05h58 HE
|
Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe...
LAMEA Insulin Syringes Market (2021 to 2027) - Size, Share & Industry Trends Analysis Report
18 mai 2022 05h33 HE
|
Research and Markets
Dublin, May 18, 2022 (GLOBE NEWSWIRE) -- The "LAMEA Insulin Syringes Market Size, By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Country and Growth Forecast,...
Global Diabetes Pipeline Landscape Insights Report, 2021 - Featuring Emerging Drugs Tirzepatide, ORMD-0801, Ladarixin, Enavogliflozin, and DBPR-108
26 nov. 2021 07h53 HE
|
Research and Markets
Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights...
Insights on the Rapid Acting Insulin Global Market to 2027 - by Product Type, Indication, Distribution Channel and Regional Outlook
22 juil. 2021 07h38 HE
|
Research and Markets
Dublin, July 22, 2021 (GLOBE NEWSWIRE) -- The "Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast,...
Worldwide Human Insulin Industry to 2026 - Key Players Include Biocon, Novo Nordisk and Pfizer Among Others
14 juil. 2021 08h08 HE
|
Research and Markets
Dublin, July 14, 2021 (GLOBE NEWSWIRE) -- The "Human Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Global Type 1 Diabetes Drug Forecast and Market Analysis Report 2021-2029 : Rise of Pump Usage and Increased Market Entry of Ultra-Rapid-Acting Insulin Formulations May Improve the Landscape
21 avr. 2021 07h13 HE
|
Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The therapeutic market...